Purchase Order HHSN302201600195P

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $9,715.00 on October 19, 2017, with an ultimate completion date of November 18, 2017. Work is performed in North Bethesda, Maryland. The order is firm fixed price with no set-aside. The source does not specify the technical scope of materials or services procured under this purchase order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Chesapeake Mission Critical LLC valued at $13,871.00 on August 25, 2017, with a completion date of September 8, 2017. Work is performed in Bethesda, Maryland. The order is priced on a firm-fixed-price basis with no set-aside applied. Specific requirements are not detailed in the source material.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 30, 2017, with a ceiling value of $7,216.30 for genomic analysis equipment and services.</p> <p>Place of performance is North Bethesda, MD. The order is priced on a firm fixed-price basis and has an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Ruro Incorporated valued at $72,140.66 on October 25, 2017, for premium support service. Place of performance is Bethesda, Maryland. The order has a firm fixed price structure and an ultimate completion date of October 31, 2018.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 23, 2017, with a ceiling value of $142,363.11 for research supplies firm fixed price.</p> <p>Place of performance is North Bethesda, Maryland. The order completes on September 28, 2017. The delivery order was issued without a set-aside designation.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Govconnection Inc. on August 30, 2017, with a ceiling value of $5,838.60 and ultimate completion date of September 30, 2017. No set-aside was used. The order is firm fixed price. Place of performance is North Bethesda, Maryland. The specific requirements for goods or services are not detailed in the source.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Golden Helix Inc. valued at $6,991.00 on June 22, 2017, for a firm fixed price.</p> <p>Place of performance is Bethesda, Maryland. The order ultimate completion date is August 1, 2018. No set-aside applies to this purchase order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to National Capitol Contracting, LLC for $12,530.00 on January 4, 2018, with performance completion by September 30, 2018. Place of performance is Bethesda, Maryland. The order was issued on a firm fixed-price basis with no set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $22,472.64 on December 18, 2018. Place of performance is Bethesda, Maryland. The order carries firm fixed price terms with an ultimate completion date of December 18, 2018. No set-aside was used. The specific goods or services procured are not identified in the source.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Harper Health &amp; Science Communications LLC for $23,996.25 on April 30, 2018. Work is performed in North Bethesda, Maryland. The order is not set-aside. Ultimate completion is scheduled for May 29, 2018. Pricing is firm fixed price.</p>